{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:00:50Z","timestamp":1792555250838,"version":"4.5.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,31]]},"DOI":"10.18632\/oncotarget.14345","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T01:27:19Z","timestamp":1482974839000},"page":"8536-8549","source":"Crossref","is-referenced-by-count":41,"title":["The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPK\u03b1\/mTOR pathway<i>in vitro<\/i>and<i>in vivo<\/i>"],"prefix":"10.18632","volume":"8","author":[{"given":"Shintaro","family":"Fujihara","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahiro","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Chiyo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohito","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Iwama","sequence":"additional","affiliation":[{"name":"Life Science Research Center, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine\/Graduate School of Medicine, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Luketich","year":"2013","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Mayer","year":"2003","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.athoracsur.2008.12.060","article-title":"Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy","volume":"87","author":"Luketich","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Nyr\u00e9n","year":"2013","journal-title":"Gut"},{"key":"5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.gastro.2015.04.053","article-title":"Epidemiology, diagnosis, and management of esophageal adenocarcinoma","volume":"149","author":"Shaheen","year":"2015","journal-title":"Gastroenterology"},{"key":"6","first-page":"1573","article-title":"Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1\/2, NF-\u03baB and survivin","volume":"34","author":"Ohta","year":"2009","journal-title":"Int J Oncol"},{"key":"7","first-page":"1251","article-title":"Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells","volume":"37","author":"Fujimura","year":"2010","journal-title":"Int J Oncol"},{"key":"8","first-page":"1893","article-title":"Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling","volume":"27","author":"Ren","year":"2012","journal-title":"Oncology Rep"},{"key":"9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2012.10.006","article-title":"Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer","volume":"328","author":"Dong","year":"2013","journal-title":"Cancer Lett"},{"key":"10","doi-asserted-by":"crossref","first-page":"e93050","DOI":"10.1371\/journal.pone.0093050","article-title":"Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells","volume":"9","author":"Narahara","year":"2014","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2014.09.019","article-title":"The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer","volume":"355","author":"Ohta","year":"2014","journal-title":"Cancer Lett"},{"key":"12","doi-asserted-by":"crossref","first-page":"e2697","DOI":"10.1136\/bmj.e2697","article-title":"Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK general practice research database","volume":"344","author":"Smeeth","year":"2012","journal-title":"BMJ"},{"key":"13","first-page":"djt374","article-title":"Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk","volume":"106","author":"Yang","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR -modulating activity","volume":"43","author":"Kurtz","year":"2004","journal-title":"Hypertension"},{"key":"15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/pros.20571","article-title":"Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action","volume":"67","author":"Uemura","year":"2007","journal-title":"Prostate"},{"key":"16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2008.03.046","article-title":"PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1","volume":"370","author":"Yanagisawa","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/0008-5472.CAN-13-1836","article-title":"Small molecule agonists of PPAR- exert therapeutic effects in esophageal cancer","volume":"74","author":"Baba","year":"2014","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ejca.2008.04.016","article-title":"Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model","volume":"44","author":"Kurakata","year":"2008","journal-title":"Eur J Cancer"},{"key":"19","first-page":"295","article-title":"Telmisartan is a potent target for prevention and treatment in human prostate cancer","volume":"20","author":"Yoshimura","year":"2008","journal-title":"Oncology Rep"},{"key":"20","first-page":"193","article-title":"Telmisartan as a peroxisome proliferator-activated receptor-gamma ligand is a new target in the treatment of human renal cell carcinoma","volume":"2","author":"Yoshimura","year":"2009","journal-title":"Mol Med Rep"},{"key":"21","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3892\/ol.2014.2592","article-title":"Antiproliferative and apoptotic effects of telmisartan in human colon cancer cells","volume":"8","author":"Grone","year":"2014","journal-title":"Oncology Lett"},{"key":"22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ardp.201300402","article-title":"Role of AMP-activated protein kinase in cancer therapy","volume":"347","author":"Hamayun","year":"2014","journal-title":"Archiv der Pharmazie"},{"key":"23","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1016\/j.febslet.2006.04.068","article-title":"The amino acid sensitive TOR pathway from yeast to mammals","volume":"580","author":"Thomas","year":"2006","journal-title":"FEBS Lett"},{"key":"24","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"Blenis","year":"2004","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2015.01.037","article-title":"Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway","volume":"239","author":"Izumiya","year":"2015","journal-title":"Atherosclerosis"},{"key":"26","doi-asserted-by":"crossref","first-page":"e96948","DOI":"10.1371\/journal.pone.0096948","article-title":"Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells","volume":"9","author":"Hirata","year":"2014","journal-title":"PLoS One"},{"key":"27","first-page":"1095","article-title":"Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma","volume":"15","author":"Lin","year":"2015","journal-title":"BMC Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/jhep.2003.50112","article-title":"Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis","volume":"37","author":"Kuriyama","year":"2003","journal-title":"Hepatology"},{"key":"29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000012067","article-title":"Prognostic value of p27Kip1 and cyclinD1 expression in esophageal cancer","volume":"57","author":"Imamura","year":"1999","journal-title":"Oncology"},{"key":"30","first-page":"329","article-title":"Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression","volume":"29","author":"Kuwano","year":"2006","journal-title":"Int J Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","article-title":"The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo","volume":"11","author":"Himoto","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"32","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin Is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Pollak","year":"2006","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Bost","year":"2008","journal-title":"Oncogene"},{"key":"34","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","article-title":"LKB1 Is the upstream kinase in the AMP-activated protein kinase cascade","volume":"13","author":"Carling","year":"2003","journal-title":"Current Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2004.06.133","article-title":"AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms","volume":"321","author":"Luo","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Nahmias","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"37","first-page":"1139","article-title":"Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor","volume":"2","author":"Kubota","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/2159-8290.CD-13-0070","article-title":"Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors","volume":"3","author":"Dinunzio","year":"2013","journal-title":"Cancer Discov"},{"key":"39","doi-asserted-by":"crossref","first-page":"C281","DOI":"10.1152\/ajpcell.00422.2003","article-title":"G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K\/AKT\/mTOR\/p70S6K1 signaling in human ovarian cancer cells","volume":"287","author":"Jiang","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/147323000002800401","article-title":"Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Roth","year":"2000","journal-title":"J Int Med Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.107.104570","article-title":"Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor signaling during endothelial aging","volume":"51","author":"Bode-Boger","year":"2008","journal-title":"Hypertension"},{"key":"42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/hepr.12386","article-title":"miRNA in hepatocellular carcinoma","volume":"45","author":"Masaki","year":"2015","journal-title":"Hepatology Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/carcin\/bgv087","article-title":"miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene","volume":"36","author":"Williams","year":"2015","journal-title":"Carcinogenesis"},{"key":"44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbrc.2015.02.101","article-title":"MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1","volume":"459","author":"Feng","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"45","first-page":"661","article-title":"Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver","volume":"26","author":"Kimura","year":"2005","journal-title":"Int J Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"48","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Gordon","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0959-8049(03)00490-8","article-title":"The combination of yondelis and cisplatin is synergistic against human tumor xenografts","volume":"39","author":"Faircloth","year":"2003","journal-title":"Eur J Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Hochberg","year":"1995","journal-title":"J Roy Stat Soc"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T13:32:45Z","timestamp":1718976765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,28]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,1,31]]}},"alternative-id":["14345","28052030"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14345","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,28]]}}}